QQQ   274.13 (+0.83%)
AAPL   461.35 (+2.06%)
MSFT   210.64 (+0.69%)
FB   261.85 (+0.75%)
GOOGL   1,518.88 (+0.77%)
AMZN   3,201.53 (+1.24%)
NVDA   461.65 (+0.88%)
CGC   17.32 (+0.41%)
BABA   253.87 (-0.52%)
TSLA   1,636.85 (+5.28%)
GE   6.62 (-1.49%)
MU   46.79 (-3.49%)
AMD   82.60 (-0.01%)
T   29.89 (-0.96%)
F   7.06 (-0.70%)
ACB   10.03 (+2.35%)
GILD   68.04 (-1.16%)
NFLX   484.10 (+1.82%)
DIS   131.65 (-0.11%)
BAC   26.25 (-1.80%)
BA   175.50 (+0.03%)
QQQ   274.13 (+0.83%)
AAPL   461.35 (+2.06%)
MSFT   210.64 (+0.69%)
FB   261.85 (+0.75%)
GOOGL   1,518.88 (+0.77%)
AMZN   3,201.53 (+1.24%)
NVDA   461.65 (+0.88%)
CGC   17.32 (+0.41%)
BABA   253.87 (-0.52%)
TSLA   1,636.85 (+5.28%)
GE   6.62 (-1.49%)
MU   46.79 (-3.49%)
AMD   82.60 (-0.01%)
T   29.89 (-0.96%)
F   7.06 (-0.70%)
ACB   10.03 (+2.35%)
GILD   68.04 (-1.16%)
NFLX   484.10 (+1.82%)
DIS   131.65 (-0.11%)
BAC   26.25 (-1.80%)
BA   175.50 (+0.03%)
QQQ   274.13 (+0.83%)
AAPL   461.35 (+2.06%)
MSFT   210.64 (+0.69%)
FB   261.85 (+0.75%)
GOOGL   1,518.88 (+0.77%)
AMZN   3,201.53 (+1.24%)
NVDA   461.65 (+0.88%)
CGC   17.32 (+0.41%)
BABA   253.87 (-0.52%)
TSLA   1,636.85 (+5.28%)
GE   6.62 (-1.49%)
MU   46.79 (-3.49%)
AMD   82.60 (-0.01%)
T   29.89 (-0.96%)
F   7.06 (-0.70%)
ACB   10.03 (+2.35%)
GILD   68.04 (-1.16%)
NFLX   484.10 (+1.82%)
DIS   131.65 (-0.11%)
BAC   26.25 (-1.80%)
BA   175.50 (+0.03%)
QQQ   274.13 (+0.83%)
AAPL   461.35 (+2.06%)
MSFT   210.64 (+0.69%)
FB   261.85 (+0.75%)
GOOGL   1,518.88 (+0.77%)
AMZN   3,201.53 (+1.24%)
NVDA   461.65 (+0.88%)
CGC   17.32 (+0.41%)
BABA   253.87 (-0.52%)
TSLA   1,636.85 (+5.28%)
GE   6.62 (-1.49%)
MU   46.79 (-3.49%)
AMD   82.60 (-0.01%)
T   29.89 (-0.96%)
F   7.06 (-0.70%)
ACB   10.03 (+2.35%)
GILD   68.04 (-1.16%)
NFLX   484.10 (+1.82%)
DIS   131.65 (-0.11%)
BAC   26.25 (-1.80%)
BA   175.50 (+0.03%)
Log in

OTCMKTS:ICOTFiCo Therapeutics Stock Price, Forecast & News

$0.03
0.00 (-7.43 %)
(As of 08/13/2020 09:30 AM ET)
Add
Compare
Today's Range
$0.03
Now: $0.03
$0.03
50-Day Range
$0.02
MA: $0.03
$0.04
52-Week Range
$0.02
Now: $0.03
$0.11
Volume4,000 shs
Average Volume44,549 shs
Market Capitalization$4.98 million
P/E RatioN/A
Dividend YieldN/A
Beta3
iCo Therapeutics Inc., a biotechnology company, focuses on the identification, development, and commercialization of drug candidates to treat sight and life threatening diseases. Its in-licensed product candidates include iCo-008, a human monoclonal antibody, which is in Phase II clinical trial to treat sight threatening ocular allergies and various systemic disease indications; and Oral AmpB Delivery System that is in pre-clinical stage used for the treatment of systemic fungal infections. The company was founded in 2005 and is headquartered in Vancouver, Canada.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.6Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.52 out of 5 stars


Industry, Sector and Symbol

Industry Pharmaceutical preparations
Sub-IndustryN/A
SectorMedical
Current SymbolOTCMKTS:ICOTF
CUSIPN/A
CIKN/A
Phone604-800-9860

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Net Income$-1,460,000.00

Miscellaneous

EmployeesN/A
Market Cap$4.98 million
Next Earnings Date8/26/2020 (Estimated)
OptionableNot Optionable
$0.03
0.00 (-7.43 %)
(As of 08/13/2020 09:30 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive ICOTF News and Ratings via Email

Sign-up to receive the latest news and ratings for ICOTF and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











iCo Therapeutics (OTCMKTS:ICOTF) Frequently Asked Questions

How has iCo Therapeutics' stock been impacted by Coronavirus?

iCo Therapeutics' stock was trading at $0.0314 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, ICOTF stock has increased by 3.2% and is now trading at $0.0324.
View which stocks have been most impacted by COVID-19
.

When is iCo Therapeutics' next earnings date?

iCo Therapeutics is scheduled to release its next quarterly earnings announcement on Wednesday, August 26th 2020.
View our earnings forecast for iCo Therapeutics
.

How were iCo Therapeutics' earnings last quarter?

iCo Therapeutics Inc (OTCMKTS:ICOTF) posted its quarterly earnings results on Friday, May, 15th. The biotechnology company reported ($0.01) earnings per share (EPS) for the quarter.
View iCo Therapeutics' earnings history
.

Has iCo Therapeutics been receiving favorable news coverage?

Media headlines about ICOTF stock have trended extremely negative this week, according to InfoTrie Sentiment. The research firm identifies negative and positive press coverage by reviewing more than six thousand blog and news sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores closest to five being the most favorable. iCo Therapeutics earned a news sentiment score of -4.1 on InfoTrie's scale. They also assigned media headlines about the biotechnology company a news buzz of 10.0 out of 10, indicating that recent press coverage is extremely likely to have an effect on the company's share price in the next few days.
View the latest news about iCo Therapeutics
.

Are investors shorting iCo Therapeutics?

iCo Therapeutics saw a drop in short interest in June. As of June 30th, there was short interest totaling 1,800 shares, a drop of 95.7% from the June 15th total of 41,800 shares. Based on an average daily volume of 11,800 shares, the short-interest ratio is currently 0.2 days.
View iCo Therapeutics' Short Interest
.

Who are some of iCo Therapeutics' key competitors?

Who are iCo Therapeutics' key executives?

iCo Therapeutics' management team includes the following people:
  • Mr. Andrew J. Rae M.B.A., BSc, MBA, Co-Founder, CEO, Pres & Director (Age 52)
  • Mr. Michael Liggett CPA, CA, Bsc. Pharm., CFO, Corp. Sec. & Director (Age 59)
  • Dr. Peter Hnik M.D., MHSc, Chief Medical Officer (Age 63)

What is iCo Therapeutics' stock symbol?

iCo Therapeutics trades on the OTCMKTS under the ticker symbol "ICOTF."

How do I buy shares of iCo Therapeutics?

Shares of ICOTF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is iCo Therapeutics' stock price today?

One share of ICOTF stock can currently be purchased for approximately $0.03.

How big of a company is iCo Therapeutics?

iCo Therapeutics has a market capitalization of $4.98 million.

What is iCo Therapeutics' official website?

The official website for iCo Therapeutics is www.icotherapeutics.com.

How can I contact iCo Therapeutics?

iCo Therapeutics' mailing address is 777 Hornby Street 6th Floor, Vancouver A1, V6Z 2T3. The biotechnology company can be reached via phone at 604-800-9860 or via email at [email protected]

This page was last updated on 8/13/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.